Price Chart

Profile

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
URL https://www.cel-sci.com
Investor Relations URL https://cel-sci.com/new-investor-information/
HQ State/Province Virginia
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release Feb. 14, 2025 (est.)
Last Earnings Release Aug. 14, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Aug. 28, 1996

Profile

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
URL https://www.cel-sci.com
Investor Relations URL https://cel-sci.com/new-investor-information/
HQ State/Province Virginia
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release Feb. 14, 2025 (est.)
Last Earnings Release Aug. 14, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Aug. 28, 1996